Skip to main content
. 2021 Apr 13;28(2):312–320. doi: 10.5603/CJ.a2019.0038

Table 2.

Baseline characteristics of the population according to short-term survival.

Patients with survival at 3-months (n = 138) Patients who died at 3-months (n = 14) P
Baseline characteristics
Age [years] 82 ± 5.3 81.8 ± 6.9 0.919
Sex (female) 39.9% (n = 55) 57.1% (n = 8) 0.259
Weight [kg] 77.8 ± 13.9 69.14 ± 13.5 0.027
Ideal weight [kg] 62.4 ± 7.3 60.1 ± 8.3 0.282
Height [cm] 167.4 ± 9.5 164.5 ± 10.6 0.291
BMI [kg/m2] 27.2 (18.1–41.7) 25.1 (16.4–37.4) 0.133
Albumin [g/dL] 4.2 (2.7–5) 3.7 (2.5–4.8) 0.018
GNRI 113.6 ± 11.8 104 ± 9.6 0.004
Frailty 66.7% (n = 92) 85.7% (n = 12) 0.227
Chronic renal failure 96.4% (n = 133) 100% (n = 14) 0.999
Carotid occlusive disease 18.1% (n = 25) 21.4% (n = 3) 0.723
Peripheral artery disease 15.9% (n = 22) 7.1% (n = 1) 0.696
Previous cardiac surgery 14.5% (n = 20) 0% (n = 0) 0.217
Previous MI 10.1% (n = 14) 14.3% (n = 2) 0.644
Previous stroke 13.8% (n = 19) 14.3% (n = 2) 0.999
Previous TIA 1.4% (n = 2) 7.1% (n = 1) 0.253
Coronary artery disease 60% (n = 80) 57.1% (n = 8)
Porcelain aorta 18.1% (n = 25) 7.1% (n = 1) 0.466
COPD 15.2% (n = 21) 21.4% (n = 3) 0.465
Diabetes 35.5% (n = 49) 28.6% (n = 4) 0.772
Hypertension 93.5% (n = 129) 85.7% (n = 12) 0.268
EuroSCORE II 5.5 ± 6.2 4.3 ± 4.5 0.482
STS score 4.0 ± 2.7 4.6 ± 3.1 0.486
Procedural characteristics
Type of valve:
 Portico 71.4% 84.6%
 Evolut 12.5% 7.7%
 Symetis 0% 7.7%
 Sapien 3 16.1% 0%
Contrast dye [mL] (n = 150) 140 (10–550) 185 (110–270) 0.096
Fluoroscopy time [min] (n = 149) 18.1 (7.9–230) 20.6 (12.7–47) 0.138
Simultaneous PCI (n = 150) 2.2% (n = 3) 7.7% (n = 1) 0.327

Bold figures show significant differences; BMI — body mass index; COPD — chronic obstructive pulmonary disease; MI — myocardial infarction; PCI — percutaneous coronary intervention; TIA — transient ischemic attack